First Heartland Consultants Inc. lifted its position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 6.3% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,240 shares of the healthcare conglomerate’s stock after acquiring an additional 74 shares during the quarter. First Heartland Consultants Inc.’s holdings in UnitedHealth Group were worth $627,000 as of its most recent filing with the SEC.
Several other large investors also recently added to or reduced their stakes in UNH. Waycross Partners LLC grew its holdings in shares of UnitedHealth Group by 2.4% during the 4th quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate’s stock valued at $14,060,000 after acquiring an additional 658 shares in the last quarter. Sherbrooke Park Advisers LLC purchased a new stake in shares of UnitedHealth Group during the 4th quarter worth about $515,000. Full Sail Capital LLC increased its holdings in UnitedHealth Group by 2.1% in the fourth quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate’s stock worth $815,000 after buying an additional 33 shares during the last quarter. Soros Fund Management LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter worth $39,413,000. Finally, Silvercrest Asset Management Group LLC boosted its holdings in UnitedHealth Group by 47.8% in the fourth quarter. Silvercrest Asset Management Group LLC now owns 38,796 shares of the healthcare conglomerate’s stock worth $19,625,000 after purchasing an additional 12,550 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.
UnitedHealth Group Price Performance
Shares of UNH opened at $303.08 on Thursday. The company’s 50-day moving average is $460.62 and its 200-day moving average is $508.74. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The firm has a market capitalization of $274.93 billion, a PE ratio of 19.55, a PEG ratio of 1.37 and a beta of 0.56. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73.
UnitedHealth Group Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 2.77%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 35.18%.
Wall Street Analysts Forecast Growth
UNH has been the topic of a number of analyst reports. Truist Financial reissued a “buy” rating and set a $360.00 price objective (down previously from $580.00) on shares of UnitedHealth Group in a report on Monday. Mizuho decreased their price objective on shares of UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating for the company in a report on Friday, May 16th. TD Cowen cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 price target for the company. in a report on Monday. Erste Group Bank lowered UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, April 30th. Finally, Robert W. Baird lowered their price objective on shares of UnitedHealth Group from $510.00 to $356.00 and set an “outperform” rating on the stock in a research note on Wednesday, May 14th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating, eighteen have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $441.87.
Check Out Our Latest Analysis on UNH
Insider Buying and Selling at UnitedHealth Group
In other UnitedHealth Group news, CEO Stephen J. Hemsley purchased 86,700 shares of UnitedHealth Group stock in a transaction that occurred on Friday, May 16th. The stock was acquired at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the transaction, the chief executive officer now owns 679,493 shares in the company, valued at $196,081,295.01. This trade represents a 14.63% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Kristen Gil bought 3,700 shares of the stock in a transaction dated Thursday, May 15th. The stock was purchased at an average price of $271.17 per share, with a total value of $1,003,329.00. Following the acquisition, the director now owns 3,818 shares of the company’s stock, valued at $1,035,327.06. The trade was a 3,135.59% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last 90 days, insiders bought 109,408 shares of company stock valued at $31,607,768. 0.33% of the stock is currently owned by company insiders.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also
- Five stocks we like better than UnitedHealth Group
- Why Are These Companies Considered Blue Chips?
- $30B AI Opportunity: Will It Power Meta’s Next Surge?
- 5 Top Rated Dividend Stocks to Consider
- Microsoft Could Rally as EU Antitrust Case Nears Resolution
- How to find penny stocks to invest and trade
- Intel Refocuses: NEX Sale and Foundry Pivot Signal New Era
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.